Latest Rights Issues News

A US court has dismissed Identitii's patent infringement claim against JPMorgan Chase, citing patent ineligibility. Identitii plans to appeal, while its core business remains unaffected.

Canadian Phosphate (ASX: CP8) is raising up to AUD 4.85 million via a renounceable rights issue at a 22% discount, aiming to accelerate development of its newly acquired Diamond Mountain Project in Utah and advance exploration in Canada.

New Talisman Gold Mines boosted revenue by 121% to NZ$53,000 but posted a $2.26 million net loss as it commissioned a processing plant and secured key commercial agreements.

VRX Silica has kicked off a $6.23 million renounceable entitlement offer, underwritten to $2 million, to fund key development activities at its Arrowsmith North silica sand project including a strategic property purchase and engineering works.

AoFrio Limited is offering existing shareholders a 1-for-7 rights issue at NZ$0.07 per share following a NZ$4.56 million placement, aiming to raise nearly NZ$5 million to fund growth ambitions.

VRX Silica’s updated 2026 Bankable Feasibility Study for Arrowsmith North confirms robust economics with an ungeared NPV8 of A$179.2 million and binding offtake contracts securing nearly 1 million tonnes annually.

American Uranium’s early infill drilling at Lo Herma confirms robust uranium mineralisation continuity in Mine Unit 1, setting the stage for a resource upgrade and scoping study in Q3 2026.

Alice Queen Limited has appointed Adrian Hell as Exploration Manager to leverage his deep knowledge of Horn Island and fast-track a multi-phase drilling campaign aimed at expanding a 524,000-ounce gold resource.

Red Sky Energy has closed a fully underwritten rights issue, securing $2.46 million from shareholders and relying on underwriting to cover a $1.69 million shortfall. The new shares will be issued today, supporting the company’s ongoing funding needs.

Mt Malcolm Mines (ASX:M2M) is gearing up for a major drilling campaign at its Calypso Gold Prospect, aiming to convert a substantial Exploration Target into a JORC-compliant Mineral Resource. The program follows high-grade discoveries at the newly identified T3 Constance Lode and historical multi-lode mineralisation.

TruScreen Group has secured NZ$1.82 million through an oversubscribed placement, underscoring investor confidence amid its global cervical screening expansion. The company also announced a renounceable rights issue and attaching options, both subject to shareholder approval.

Alternative Investment Trust (AIQ) has issued 7.39 million units at A$1.38 each, raising A$10.2 million from wholesale investors without a product disclosure statement. The capital raise aligns with AIQ’s adjusted net tangible asset value and complies with Corporations Act requirements.